Malaria therapeutics: are we close enough?

Parasit Vectors. 2023 Apr 14;16(1):130. doi: 10.1186/s13071-023-05755-8.

Abstract

Malaria is a vector-borne parasitic disease caused by the apicomplexan protozoan parasite Plasmodium. Malaria is a significant health problem and the leading cause of socioeconomic losses in developing countries. WHO approved several antimalarials in the last 2 decades, but the growing resistance against the available drugs has worsened the scenario. Drug resistance and diversity among Plasmodium strains hinder the path of eradicating malaria leading to the use of new technologies and strategies to develop effective vaccines and drugs. A timely and accurate diagnosis is crucial for any disease, including malaria. The available diagnostic methods for malaria include microscopy, RDT, PCR, and non-invasive diagnosis. Recently, there have been several developments in detecting malaria, with improvements leading to achieving an accurate, quick, cost-effective, and non-invasive diagnostic tool for malaria. Several vaccine candidates with new methods and antigens are under investigation and moving forward to be considered for clinical trials. This article concisely reviews basic malaria biology, the parasite's life cycle, approved drugs, vaccine candidates, and available diagnostic approaches. It emphasizes new avenues of therapeutics for malaria.

Keywords: Diagnostics; Malaria therapeutics; Plasmodium species; RTS,S; Rapid diagnostic test; Vaccine.

Publication types

  • Review

MeSH terms

  • Antigens, Protozoan / genetics
  • Antimalarials* / therapeutic use
  • Humans
  • Malaria Vaccines* / therapeutic use
  • Malaria* / diagnosis
  • Malaria* / drug therapy
  • Malaria* / prevention & control
  • Malaria, Falciparum* / drug therapy
  • Plasmodium falciparum
  • Plasmodium* / genetics

Substances

  • Malaria Vaccines
  • Antimalarials
  • Antigens, Protozoan